Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MitoQ supplementation plus endurance training in women with multiple sclerosis
IRCT20221120056558N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Jun 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of mitoquinone in multiple sclerosis (MS), sponsored by Kerman University of Medical Sciences. Primary endpoints: Cognitive function and Motor function. Started Jun 2023; status: completed.
02
Drugs
mitoquinone
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT20221120056558N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221120056558N1.